EMA post approval change guidance:European Medicines Agency post
European Medicines Agency post
2005年10月10日—post-authorisationguidance“Changingthe(invented)nameofacentrallyauthorisedmedicine:Page174/215.Page175.questionsandanswers ...。其他文章還包含有:「Post」、「Classificationofchanges」、「Post」、「EMAupdatesGuidanceforPost」、「EMAGuidance」、「IndustryPositionPaper」、「PracticalguidanceforproceduresrelatedtoBrexitfor...」
查看更多 離開網站Post
https://www.ema.europa.eu
Question-and-answer (Q&A) document. EMA's post-authorisation procedural advice document provides a printable overview in Q&A format of EMA's position on issues ...
Classification of changes
https://www.ema.europa.eu
For additional guidance on changes to existing presentation that can trigger new EU number(s) please see the EMA post-authorisation guidance for Type IA, Type ...
Post
https://nodeviation.com
In this article, we intend to systemically lay out the different risk-based approaches for post-approval changes across FDA, EMA and HSA.
EMA updates Guidance for Post
https://www.gmp-compliance.org
The EMA announced on July 14, 2017, that it has revised three post-authorization activity guidance documents, including type II variations, ...
EMA Guidance
https://www.regulatoryaffairsn
The guidance outlines the various post-authorisation procedures and their respective timelines. It covers variations, renewals, line extensions, ...
Industry Position Paper
https://www.efpia.eu
National Regulatory Authorities (NRAs) should: establish national or regional guidelines in line with international standards (with regard to a ...
Practical guidance for procedures related to Brexit for ...
https://www.ejprarediseases.or
The below Practical Guidance aims to provide procedural and practical guidance regarding submission of changes and related fees. It has been updated to ...